The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...

GLP-1 agonists work by suppressing patients’ appetites and have been approved to treat obesity and type 2 diabetes in the ...

The launch of Mounjaro always raised the risk that it would cannibalise sales of Lilly's own GLP-1 agonist Trulicity (dulaglutide ... to demonstrate that the weight loss achieved with the ...

“Our independent committee was presented with clinical evidence which showed that people lose more weight with liraglutide ... Eli Lilly’s Trulicity (dulaglutide), which grew 22% to $3.57 ...

One person who wanted to try the drug said it took a lot of convincing. They wrote: "I went to my doctor and was in tears ...

As for why it’s not approved for weight loss in the UK, Dr Kayat added: “It works by helping to regulate your appetite and ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

The secret to losing weight could all be down to a combination of 14 'skinny genes', a new study has found. Researchers discovered they helped people drop twice as much weight when they ran for half ...